EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 202 filers reported holding EDITAS MEDICINE INC in Q1 2019. The put-call ratio across all filers is 2.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $505,000 | +45.5% | 17,028 | +11.9% | 0.00% | +50.0% |
| Q3 2019 | $347,000 | -2.0% | 15,223 | +6.1% | 0.00% | -33.3% |
| Q2 2019 | $354,000 | +5.4% | 14,342 | +2.6% | 0.00% | 0.0% |
| Q1 2019 | $336,000 | +45.5% | 13,981 | +38.0% | 0.00% | +50.0% |
| Q4 2018 | $231,000 | -42.1% | 10,134 | -19.4% | 0.00% | -33.3% |
| Q3 2018 | $399,000 | +16.7% | 12,581 | +22.0% | 0.00% | 0.0% |
| Q2 2018 | $342,000 | 0.0% | 10,314 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $342,000 | +280.0% | 10,314 | +252.6% | 0.00% | +200.0% |
| Q4 2017 | $90,000 | +200.0% | 2,925 | +129.4% | 0.00% | – |
| Q3 2017 | $30,000 | +50.0% | 1,275 | +6.2% | 0.00% | – |
| Q2 2017 | $20,000 | -16.7% | 1,200 | +9.1% | 0.00% | – |
| Q1 2017 | $24,000 | +4.3% | 1,100 | -23.1% | 0.00% | – |
| Q4 2016 | $23,000 | +9.5% | 1,430 | -12.3% | 0.00% | – |
| Q3 2016 | $21,000 | +61.5% | 1,630 | +207.5% | 0.00% | – |
| Q2 2016 | $13,000 | – | 530 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |